Premise: FDA estimates the overall compliance costs of the rule to be from $174 million to $187 million in one-time costs and $149 million to $185 million in annual operating costs.

Hypothesis: The FDA expects the compliance costs of the rule to dramatically decrease operating costs on an annual basis.
Relation: contradiction